Meta-analysis of antidepressant treatment for patients with poststroke depression [10]

Stroke

Volumn 37, Issue 6, 2006, Pages 1365-1366

  Chen, Yan ^a   Guo, Jeff J ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; HUMAN; LETTER; META ANALYSIS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CEREBROVASCULAR ACCIDENT; NOTE; PSYCHOLOGICAL ASPECT;

ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; DEPRESSION; HUMANS; META-ANALYSIS;

EID: 33745133397     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000222914.83670.05     Document Type: Letter

References (10)

1. Hackett ML, Anderson CS, House AO. Management of depression after stroke. A systematic review of pharmacological therapies. Stroke. 2005;36:1092-1097.
2. Hunter JE, Schmidt FL, Method of Meta-Analysis: correcting error and bias in research findings. Newbury Park, CA: Sage; 1990.
3. Lipsey MW, Wilson DB. Practical meta-analysis (Applied social research methods series; v 49). Thousand Oaks, CA: Sage, 2001.
4. Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Strakstein SE. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled double-blind study. Am J Psychiatry. 2000;157:351-359.
5. Lipsey J, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet. 1984;1:297-300.
6. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099-1104.
7. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of poststorke depression: a three months double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250:347-351.
8. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo controlled study. Stroke. 2000;31:1829-1832.
9. Murray V, Von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, Nasman P, Olsson JE, Samuelsson M, Terent A, Varelius R, Asberg M, Martensson B. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66:708-716.
10. Joliat MJ, Schmidt ME, Fava M, Zhang S, Michelson D, Trapp NJ, Miner CM. Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine. J Clin Psychiatry. 2004;65:373-378.